Emory Transplant Center (ETC) patients are now benefiting from a new class of FDA-approved transplant drugs that Emory surgeons and scientists helped pioneer called Nulojix® (belatacept), for the prevention of graft rejection after kidney transplant.
Emory Healthcare 